ID   NAGK_HUMAN              Reviewed;         344 AA.
AC   Q9UJ70; B4DLZ5; Q53HD5; Q6IA84; Q9BS29; Q9BVP0; Q9NV37;
DT   01-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   15-MAR-2017, entry version 150.
DE   RecName: Full=N-acetyl-D-glucosamine kinase;
DE            Short=N-acetylglucosamine kinase;
DE            EC=2.7.1.59;
DE   AltName: Full=GlcNAc kinase;
GN   Name=NAGK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=10824116; DOI=10.1046/j.1432-1327.2000.01360.x;
RA   Hinderlich S., Berger M., Schwarzkopf M., Effertz K., Reutter W.;
RT   "Molecular cloning and characterization of murine and human N-
RT   acetylglucosamine kinase.";
RL   Eur. J. Biochem. 267:3301-3308(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   ARG-38 AND VAL-60.
RC   TISSUE=Kidney, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-14.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   PROTEIN SEQUENCE OF 245-261 AND 281-291, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [10]
RP   PHOSPHORYLATION AT TYR-205.
RX   PubMed=12112843;
RX   DOI=10.1002/1615-9861(200206)2:6<642::AID-PROT642>3.0.CO;2-I;
RA   Maguire P.B., Wynne K.J., Harney D.F., O'Donoghue N.M., Stephens G.,
RA   Fitzgerald D.J.;
RT   "Identification of the phosphotyrosine proteome from thrombin
RT   activated platelets.";
RL   Proteomics 2:642-648(2002).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=22692205; DOI=10.1074/jbc.M112.363549;
RA   Bergfeld A.K., Pearce O.M., Diaz S.L., Pham T., Varki A.;
RT   "Metabolism of vertebrate amino sugars with N-glycolyl groups:
RT   elucidating the intracellular fate of the non-human sialic acid N-
RT   glycolylneuraminic acid.";
RL   J. Biol. Chem. 287:28865-28881(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1-345 IN COMPLEXES WITH
RP   SUBSTRATE; GLUCOSE AND ADP, AND SUBUNIT.
RX   PubMed=17010375; DOI=10.1016/j.jmb.2006.08.085;
RA   Weihofen W.A., Berger M., Chen H., Saenger W., Hinderlich S.;
RT   "Structures of human N-acetylglucosamine kinase in two complexes with
RT   N-acetylglucosamine and with ADP/glucose: insights into substrate
RT   specificity and regulation.";
RL   J. Mol. Biol. 364:388-399(2006).
CC   -!- FUNCTION: Converts endogenous N-acetylglucosamine (GlcNAc), a
CC       major component of complex carbohydrates, from lysosomal
CC       degradation or nutritional sources into GlcNAc 6-phosphate.
CC       Involved in the N-glycolylneuraminic acid (Neu5Gc) degradation
CC       pathway: although human is not able to catalyze formation of
CC       Neu5Gc due to the inactive CMAHP enzyme, Neu5Gc is present in food
CC       and must be degraded. Also has ManNAc kinase activity.
CC       {ECO:0000269|PubMed:22692205}.
CC   -!- CATALYTIC ACTIVITY: ATP + N-acetyl-D-glucosamine = ADP + N-acetyl-
CC       D-glucosamine 6-phosphate. {ECO:0000269|PubMed:22692205}.
CC   -!- PATHWAY: Amino-sugar metabolism; N-acetylneuraminate degradation.
CC       {ECO:0000269|PubMed:22692205}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17010375}.
CC   -!- INTERACTION:
CC       B2R7W0:-; NbExp=3; IntAct=EBI-372578, EBI-10175537;
CC       Q9NZ32:ACTR10; NbExp=3; IntAct=EBI-372578, EBI-2559426;
CC       P42773:CDKN2C; NbExp=3; IntAct=EBI-11526455, EBI-711290;
CC       Q9UI36:DACH1; NbExp=3; IntAct=EBI-372578, EBI-347111;
CC       Q9UI36-2:DACH1; NbExp=5; IntAct=EBI-372578, EBI-10186082;
CC       P25800:LMO1; NbExp=4; IntAct=EBI-11526455, EBI-8639312;
CC       Q8TBB1:LNX1; NbExp=2; IntAct=EBI-372578, EBI-739832;
CC       P50221:MEOX1; NbExp=3; IntAct=EBI-372578, EBI-2864512;
CC       Q04864:REL; NbExp=3; IntAct=EBI-372578, EBI-307352;
CC       O00560:SDCBP; NbExp=5; IntAct=EBI-372578, EBI-727004;
CC       Q99081:TCF12; NbExp=3; IntAct=EBI-372578, EBI-722877;
CC       Q96HA8:WDYHV1; NbExp=4; IntAct=EBI-11526455, EBI-741158;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UJ70-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UJ70-2; Sequence=VSP_044586;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10824116}.
CC   -!- SIMILARITY: Belongs to the eukaryotic-type N-acetylglucosamine
CC       kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ242910; CAB61848.1; -; mRNA.
DR   EMBL; AK001812; BAA91923.1; -; mRNA.
DR   EMBL; AK297224; BAG59707.1; -; mRNA.
DR   EMBL; CR457271; CAG33552.1; -; mRNA.
DR   EMBL; AK222645; BAD96365.1; -; mRNA.
DR   EMBL; AC007881; AAY14748.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99780.1; -; Genomic_DNA.
DR   EMBL; BC001029; AAH01029.1; -; mRNA.
DR   EMBL; BC005371; AAH05371.1; -; mRNA.
DR   CCDS; CCDS33220.2; -. [Q9UJ70-2]
DR   RefSeq; NP_060037.3; NM_017567.4. [Q9UJ70-2]
DR   UniGene; Hs.7036; -.
DR   PDB; 2CH5; X-ray; 1.90 A; A/B/C/D=1-344.
DR   PDB; 2CH6; X-ray; 2.72 A; A/B/C/D=1-344.
DR   PDBsum; 2CH5; -.
DR   PDBsum; 2CH6; -.
DR   ProteinModelPortal; Q9UJ70; -.
DR   SMR; Q9UJ70; -.
DR   BioGrid; 120728; 82.
DR   IntAct; Q9UJ70; 37.
DR   MINT; MINT-1182067; -.
DR   STRING; 9606.ENSP00000389087; -.
DR   DrugBank; DB00141; N-Acetyl-D-glucosamine.
DR   iPTMnet; Q9UJ70; -.
DR   PhosphoSitePlus; Q9UJ70; -.
DR   SwissPalm; Q9UJ70; -.
DR   BioMuta; NAGK; -.
DR   DMDM; 24638065; -.
DR   OGP; Q9UJ70; -.
DR   EPD; Q9UJ70; -.
DR   PaxDb; Q9UJ70; -.
DR   PeptideAtlas; Q9UJ70; -.
DR   PRIDE; Q9UJ70; -.
DR   DNASU; 55577; -.
DR   Ensembl; ENST00000244204; ENSP00000244204; ENSG00000124357. [Q9UJ70-1]
DR   Ensembl; ENST00000455662; ENSP00000389087; ENSG00000124357. [Q9UJ70-2]
DR   Ensembl; ENST00000613852; ENSP00000477639; ENSG00000124357. [Q9UJ70-2]
DR   GeneID; 55577; -.
DR   KEGG; hsa:55577; -.
DR   UCSC; uc002shp.4; human. [Q9UJ70-1]
DR   CTD; 55577; -.
DR   DisGeNET; 55577; -.
DR   GeneCards; NAGK; -.
DR   H-InvDB; HIX0002147; -.
DR   HGNC; HGNC:17174; NAGK.
DR   HPA; HPA035206; -.
DR   HPA; HPA035207; -.
DR   MIM; 606828; gene.
DR   neXtProt; NX_Q9UJ70; -.
DR   OpenTargets; ENSG00000124357; -.
DR   PharmGKB; PA31436; -.
DR   eggNOG; KOG1794; Eukaryota.
DR   eggNOG; COG2971; LUCA.
DR   GeneTree; ENSGT00510000047418; -.
DR   HOGENOM; HOG000007248; -.
DR   HOVERGEN; HBG052570; -.
DR   InParanoid; Q9UJ70; -.
DR   KO; K00884; -.
DR   OMA; PVEKTWA; -.
DR   OrthoDB; EOG091G0LXR; -.
DR   PhylomeDB; Q9UJ70; -.
DR   TreeFam; TF314158; -.
DR   BRENDA; 2.7.1.59; 2681.
DR   Reactome; R-HSA-446210; Synthesis of UDP-N-acetyl-glucosamine.
DR   UniPathway; UPA00629; -.
DR   ChiTaRS; NAGK; human.
DR   EvolutionaryTrace; Q9UJ70; -.
DR   GeneWiki; NAGK; -.
DR   GenomeRNAi; 55577; -.
DR   PRO; PR:Q9UJ70; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000124357; -.
DR   CleanEx; HS_NAGK; -.
DR   ExpressionAtlas; Q9UJ70; baseline and differential.
DR   Genevisible; Q9UJ70; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0045127; F:N-acetylglucosamine kinase activity; IDA:UniProtKB.
DR   GO; GO:0009384; F:N-acylmannosamine kinase activity; IEA:Ensembl.
DR   GO; GO:0006044; P:N-acetylglucosamine metabolic process; TAS:ProtInc.
DR   GO; GO:0006051; P:N-acetylmannosamine metabolic process; TAS:ProtInc.
DR   GO; GO:0019262; P:N-acetylneuraminate catabolic process; TAS:UniProtKB.
DR   GO; GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; TAS:Reactome.
DR   InterPro; IPR002731; ATPase_BadF.
DR   Pfam; PF01869; BcrAD_BadFG; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Direct protein sequencing; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    344       N-acetyl-D-glucosamine kinase.
FT                                /FTId=PRO_0000096696.
FT   REGION      129    130       Substrate binding. {ECO:0000244|PDB:2CH5,
FT                                ECO:0000269|PubMed:17010375}.
FT   REGION      145    147       Substrate binding. {ECO:0000244|PDB:2CH5,
FT                                ECO:0000269|PubMed:17010375}.
FT   BINDING      13     13       ATP; via amide nitrogen.
FT                                {ECO:0000244|PDB:2CH6,
FT                                ECO:0000305|PubMed:17010375}.
FT   BINDING      36     36       Substrate. {ECO:0000244|PDB:2CH5,
FT                                ECO:0000269|PubMed:17010375}.
FT   BINDING     107    107       Substrate. {ECO:0000244|PDB:2CH5,
FT                                ECO:0000269|PubMed:17010375}.
FT   BINDING     127    127       ATP. {ECO:0000244|PDB:2CH6,
FT                                ECO:0000305|PubMed:17010375}.
FT   BINDING     152    152       Substrate. {ECO:0000244|PDB:2CH5,
FT                                ECO:0000269|PubMed:17010375}.
FT   BINDING     214    214       ATP; via carbonyl oxygen.
FT                                {ECO:0000244|PDB:2CH6,
FT                                ECO:0000305|PubMed:17010375}.
FT   BINDING     271    271       ATP. {ECO:0000244|PDB:2CH6,
FT                                ECO:0000305|PubMed:17010375}.
FT   BINDING     275    275       ATP. {ECO:0000244|PDB:2CH6,
FT                                ECO:0000305|PubMed:17010375}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES      76     76       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     205    205       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:12112843}.
FT   VAR_SEQ       1      1       M -> MRTRTGSQLAAREVTGSGAVPRQLEGRRCQAGRDAN
FT                                GGTSSDGSSSM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044586.
FT   VARIANT      38     38       W -> R (in dbSNP:rs17856147).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_029763.
FT   VARIANT      60     60       A -> V (in dbSNP:rs17849984).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_029764.
FT   CONFLICT     70     70       S -> I (in Ref. 1; CAB61848).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       V -> I (in Ref. 1; CAB61848).
FT                                {ECO:0000305}.
FT   CONFLICT    211    211       C -> Y (in Ref. 4; BAD96365).
FT                                {ECO:0000305}.
FT   CONFLICT    286    286       A -> V (in Ref. 2; BAA91923).
FT                                {ECO:0000305}.
FT   CONFLICT    324    324       G -> R (in Ref. 2; BAA91923).
FT                                {ECO:0000305}.
FT   STRAND        4     10       {ECO:0000244|PDB:2CH5}.
FT   STRAND       15     21       {ECO:0000244|PDB:2CH5}.
FT   STRAND       26     32       {ECO:0000244|PDB:2CH5}.
FT   HELIX        37     40       {ECO:0000244|PDB:2CH5}.
FT   HELIX        42     60       {ECO:0000244|PDB:2CH5}.
FT   STRAND       64     66       {ECO:0000244|PDB:2CH6}.
FT   STRAND       68     75       {ECO:0000244|PDB:2CH5}.
FT   TURN         76     79       {ECO:0000244|PDB:2CH5}.
FT   HELIX        81     94       {ECO:0000244|PDB:2CH5}.
FT   STRAND       98    100       {ECO:0000244|PDB:2CH5}.
FT   STRAND      102    106       {ECO:0000244|PDB:2CH5}.
FT   HELIX       107    115       {ECO:0000244|PDB:2CH5}.
FT   STRAND      120    134       {ECO:0000244|PDB:2CH5}.
FT   STRAND      136    138       {ECO:0000244|PDB:2CH6}.
FT   STRAND      140    144       {ECO:0000244|PDB:2CH5}.
FT   TURN        148    150       {ECO:0000244|PDB:2CH5}.
FT   HELIX       156    171       {ECO:0000244|PDB:2CH5}.
FT   HELIX       182    192       {ECO:0000244|PDB:2CH5}.
FT   HELIX       197    201       {ECO:0000244|PDB:2CH5}.
FT   TURN        202    207       {ECO:0000244|PDB:2CH5}.
FT   HELIX       210    214       {ECO:0000244|PDB:2CH5}.
FT   HELIX       217    225       {ECO:0000244|PDB:2CH5}.
FT   HELIX       229    249       {ECO:0000244|PDB:2CH5}.
FT   HELIX       250    252       {ECO:0000244|PDB:2CH5}.
FT   HELIX       255    258       {ECO:0000244|PDB:2CH5}.
FT   STRAND      259    262       {ECO:0000244|PDB:2CH6}.
FT   STRAND      264    270       {ECO:0000244|PDB:2CH5}.
FT   HELIX       271    275       {ECO:0000244|PDB:2CH5}.
FT   HELIX       276    290       {ECO:0000244|PDB:2CH5}.
FT   STRAND      300    309       {ECO:0000244|PDB:2CH5}.
FT   HELIX       312    321       {ECO:0000244|PDB:2CH5}.
FT   TURN        322    324       {ECO:0000244|PDB:2CH5}.
FT   HELIX       331    334       {ECO:0000244|PDB:2CH5}.
FT   STRAND      335    342       {ECO:0000244|PDB:2CH5}.
SQ   SEQUENCE   344 AA;  37376 MW;  FCBB6B328EF4D515 CRC64;
     MAAIYGGVEG GGTRSEVLLV SEDGKILAEA DGLSTNHWLI GTDKCVERIN EMVNRAKRKA
     GVDPLVPLRS LGLSLSGGDQ EDAGRILIEE LRDRFPYLSE SYLITTDAAG SIATATPDGG
     VVLISGTGSN CRLINPDGSE SGCGGWGHMM GDEGSAYWIA HQAVKIVFDS IDNLEAAPHD
     IGYVKQAMFH YFQVPDRLGI LTHLYRDFDK CRFAGFCRKI AEGAQQGDPL SRYIFRKAGE
     MLGRHIVAVL PEIDPVLFQG KIGLPILCVG SVWKSWELLK EGFLLALTQG REIQAQNFFS
     SFTLMKLRHS SALGGASLGA RHIGHLLPMD YSANAIAFYS YTFS
//
